Owen, MJ, Sawa, A, Mortensen, PB. Schizophrenia. Lancet
2016; 388: 86–97.
Chong, HY, Teoh, SL, Wu, DB, Kotirum, S, Chiou, CF, Chaiyakunapruk, N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat
2016; 12: 357–73.
Wu, EQ, Birnbaum, HG, Shi, L, Ball, DE, Kessler, RC, Moulis, M, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry
2005; 66: 1122–9.
Cloutier, M, Aigbogun, MS, Guerin, A, Nitulescu, R, Ramanakumar, AV, Kamat, SA, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry
2016; 77: 764–71.
Saha, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
Arch Gen Psychiatry
2007; 64: 1123–31.
Bushe, CJ, Taylor, M, Haukka, J. Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol
2010; 24: 17–25.
Laursen, TM, Nordentoft, M, Mortensen, PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol
2014; 10: 425–48.
Chou, FH, Tsai, KY, Wu, HC, Shen, SP. Cancer in patients with schizophrenia: what is the next step?
Psychiatry Clin Neurosci
2016; 70: 473–88.
Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry
2015; 72: 1172–81.
Brown, S, Kim, M, Mitchell, C, Inskip, H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry
2010; 196: 116–21.
Reininghaus, U, Dutta, R, Dazzan, P, Doody, GA, Fearon, P, Lappin, J, et al. Mortality in schizophrenia and other psychoses: a 10-year follow-up of the SOP first-episode cohort. Schizophr Bull
2015; 41: 664–73.
Walker, ER, McGee, RE, Druss, BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry
2015; 72: 334–41.
Crump, C, Winkleby, MA, Sundquist, K, Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry
2013; 170: 324–33.
Mortensen, PB, Juel, K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand
1990; 81: 372–7.
Saku, M, Tokudome, S, Ikeda, M, Kono, S, Makimoto, K, Uchimura, H, et al. Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol
1995; 24: 366–72.
Lawrence, D, Holman, CD, Jablensky, AV, Threlfall, TJ, Fuller, SA. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand
2000; 101: 382–8.
Laursen, TM, Munk-Oisen, T, Nordentoft, M, Mortensen, PB. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry
2007; 68: 899–907.
Castagnini, A, Foldager, L, Bertelsen, A. Excess mortality of acute and transient psychotic disorders: Comparison with bipolar affective disorder and schizophrenia. Acta Psychiatr Scand
2013; 128: 370–5.
Heila, H, Haukka, J, Suvisaari, J, Lonnqvist, J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med
2005; 35: 725–32.
Tran, E, Rouillon, F, Loze, JY, Casadebaig, F, Philippe, A, Vitry, F, et al. Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer
2009; 115: 3555–62.
Daumit, GL, Anthony, CB, Ford, DE, Fahey, M, Skinner, EA, Lehman, AF, et al. Pattern of mortality in a sample of Maryland residents with severe mental illness. Psychiatry Res
2010; 176: 242–5.
Talaslahti, T, Alanen, HM, Hakko, H, Isohanni, M, Häkkinen, U, Leinonen, E. Mortality and causes of death in older patients with schizophrenia, Int J Geriatr Psychiatry
2012; 27: 1131–7.
Guan, NC, Termorshuizen, F, Laan, W, Smeets, HM, Zainal, NZ, Kahn, RS, et al. Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol
2013; 48: 1289–95.
Kisely, S, Crowe, E, Lawrence, D. Cancer-related mortality in people with mental illness. JAMA Psychiatry
2013; 70: 209–17.
Almeida, OP, Hankey, GJ, Yeap, BB, Golledge, J, Norman, PE, Flicker, L. Mortality among people with severe mental disorders who reach old age: a longitudinal study of a community-representative sample of 37,892 men. PloS One
2014; 9: e111882.
Kredentser, MS, Martens, PJ, Chochinov, HM, Prior, HJ. Cause and rate of death in people with schizophrenia across the lifespan: a population-based study in Manitoba, Canada. J Clin Psychiatry
2014; 75: 154–61.
Kisely, S, Forsyth, S, Lawrence, D. Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower?
Aust NZ J Psychiatry
2016; 50: 254–63.
Hodgson, R, Wildgust, HJ, Bushe, CJ. Cancer and schizophrenia: is there a paradox?
2010; 24: 51–60.
Bushe, CJ, Hodgson, R. Schizophrenia and cancer: in 2010 do we understand the connection?
Can J Psychiatry
2010; 55: 761–7.
Catala-Lopez, F, Suarez-Pinilla, M, Suarez-Pinilla, P, Valderas, JM, Gomez-Beneyto, M, Martinez, S, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom
2014; 83: 89–105.
Dalton, SO, Laursen, TM, Mellemkjaer, L, Johansen, C, Mortensen, PB. Risk for cancer in parents of patients with schizophrenia. Am J Psychiatry
2004; 161: 903–8.
Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA
2000; 283: 2008–12.
Brown, S, Inskip, H, Barraclough, B. Causes of the excess mortality of schizophrenia. Br J Psychiatry
2000; 177: 212–7.
Grigoletti, L, Perini, G, Rossi, A, Biggeri, A, Barbui, C, Tansella, M, et al. Mortality and cause of death among psychiatric patients: a 20-year case-register study in an area with a community-based system of care. Psychol Med
2009; 39: 1875–84.
Perini, G, Grigoletti, L, Hanife, B, Biggeri, A, Tansella, M, Amaddeo, F. Cancer mortality among psychiatric patients treated in a community-based system of care: a 25-year case register study. Soc Psychiatry Psychiatr Epidemiol
2014; 49: 693–701.
Batty, GD, Whitley, E, Gale, CR, Osborn, D, Tynelius, P, Rasmussen, F. Impact of mental health problems on case fatality in male cancer patients. Br J Cancer
2012; 106: 1842–5.
DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trials
1986; 7: 177–88.
Altman, DG, Bland, JM. How to obtain the confidence interval from a P value. BMJ
2011; 343: d2090.
Higgins, JP, Thompson, SG. Quantifying heterogeneity in a meta-analysis. Stat Med
2002; 21: 1539–58.
Egger, M, Davey Smith, G, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test, BMJ
1997; 315: 629–34.
Mortensen, PB, Juel, K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry
1993; 163: 183–9.
Chou, FH, Tsai, KY, Su, CY, Lee, CC. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res
2011; 129: 97–103.
Bergamo, C, Sigel, K, Mhango, G, Kale, M, Wisnivesky, JP. Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study. Psychosom Med
2014; 76: 215–20.
Beary, M, Hodgson, R, Wildgust, HJ. A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications. J Psychopharmacol
2012; 26: 52–61.
Cunningham, R, Sarfati, D, Stanley, J, Peterson, D, Collings, S. Cancer survival in the context of mental illness: a national cohort study. Gen Hosp Psychiatry
2015; 37: 501–6.
Mitchell, AJ, Pereira, IE, Yadegarfar, M, Pepereke, S, Mugadza, V, Stubbs, B. Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake. Br J Psychiatry
2014; 205: 428–35.
Stubbs, B, Koyanagi, A, Veronese, N, Vancampfort, D, Solmi, M, Gaughran, F, et al. Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries. BMC Med
2016; 14: 189.
Mitchell, AJ, Vancampfort, D, De Hert, M, Stubbs, B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis. Gen Hosp Psychiatry
2015; 37: 14–23.
Tiihonen, J, Lonnqvist, J, Wahlbeck, K, Klaukka, T, Niskanen, L, Tanskanen, A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet
2009; 374: 620–7.
De Hert, M, Peuskens, J, Sabbe, T, Mitchell, AJ, Stubbs, B, Neven, P, et al. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand
2016; 133: 5–22.
Froes Brandao, D, Strasser-Weippl, K, Goss, PE. Prolactin and breast cancer: the need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: a review. Cancer
2016; 122: 184–8.
De Hert, M, Vancampfort, D, Stubbs, B, Sabbe, T, Wildiers, H, Detraux, J. Antipsychotic treatment, prolactin, and breast tumorigenesis. Psychiatr Danub
2016; 28: 243–54.
Jones, ME, Swerdlow, AJ. Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol
1998; 148: 1012–7.
Card, TR, Solaymani-Dodaran, M, Hubbard, R, Logan, RF, West, J. Is an internal comparison better than using national data when estimating mortality in longitudinal studies?
J Epidemiol Community Health
2006; 60: 819–21.